On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayJul 25, 2016 1:59 pm

Broadwind Energy, Inc. (BWEN) Secures $15 Million in New Wind Turbine Tower Orders

Broadwind Energy, Inc. (NASDAQ: BWEN) recently announced the reception of $15 million in new wind turbine tower orders. The contract is expected to be completed in the fourth quarter of this year. The company plans to produce these towers in its Manitowoc, Wisconsin, facility ahead of scheduled delivery in 2017. “We are pleased to be awarded this order for 2017 production,” Stephanie Kushner, president and chief executive officer of Broadwind, stated in a news release. “There is a lot of positive momentum occurring within our Towers business as we continue to benefit from the strong wind market dynamics in the…

Continue Reading

FridayJul 22, 2016 12:47 pm

Bovie Medical (BVX) says Hologic to Market J-Plasma in the U.S.

On July 21, 2016, Bovie Medical (NYSEMKT: BVX) announced (http://nnw.fm/WWw3V) the signing of a sales channel partnership agreement, which takes immediate effect, with Hologic (NASDAQ: HOLX). In announcing the agreement, Bovie Medical’s CEO, Robert L. Gershon, affirmed: “We are proud to partner with a Company of Hologic’s caliber. This agreement is an important milestone in our strategy to scale J-Plasma® through select sales channel partnerships across multiple specialties that represent large addressable market opportunities.” J-Plasma® will initially be added to Hologic’s world-class portfolio of healthcare solutions in gynecological and gynecological/oncological surgery in three U.S. regions. The agreement, which is for…

Continue Reading

FridayJul 22, 2016 12:35 pm

Organovo (ONVO) signs First Customer Orders for Access Program as it prepares to take Kidney Tissue to Market

On July 20, 2016, Organovo Holdings, Inc. (NYSEMKT: ONVO) (“Organovo”), a biotech company that employs three-dimensional (3D) printing technology to produce tissue (bio-printing), announced that it is on track to commercialize its second tissue, the kidney proximal tubule, by the end of the third quarter 2016. The company has begun a number of pre-commercialization activities, one of which is an early access program for preferred partners, and has received the first customer orders under that program. A number of other biopharmaceutical companies have expressed interest in the early access program. “The power and versatility of our technology platform allows us…

Continue Reading

ThursdayJul 21, 2016 1:31 pm

WRIT Media Group, Inc. (WRIT) Secures Capital through New Funding Round

Before the opening bell, WRIT Media Group, Inc. (OTCQB: WRIT) took a significant step toward the completion of the final phase of development for its proprietary CrypStock digital trading platform when it announced securement of an additional $100,000 in capital through a new funding round. The financing comes as the result of a co-investment by one of the company’s existing investors and a private equity firm. WRIT intends to allocate this capital to the completion of its SEC filings, as well as the payment of expenses associated with the recent acquisition of Pandora Venture Capital and Pelecoin digital currency. “This…

Continue Reading

ThursdayJul 21, 2016 1:10 pm

Energy Recovery, Inc. (ERII) $11 Million IsoBoost™ Deal Demonstrates Prowess/Potential of Rising Gas Processing Star

In the past decade alone, the energy sector has seen a decided shift toward wringing out every last drop of energy from the logistics of production, a process spurred on by global cries to reduce harmful emissions, as well as more immediate industry goals such as enhanced profitability, output, and overall efficiency. At the forefront of this push are a variety of players, each bringing different advantages to the market via innovative systems that could collectively help to transform the entire energy equation and put us on a path to a much brighter tomorrow. One such entity is award-winning pump…

Continue Reading

ThursdayJul 21, 2016 12:27 pm

FDA grants Breakthrough Therapy Designation to AveXis’ (AVXS) AVXS-101 Gene Therapy for Pediatric Spinal Muscular Atrophy Type 1

AveXis, Inc. (NASDAQ: AVXS), a clinical-stage gene therapy biotech company focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases, announced on Wednesday, July 20, 2016, that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to AVXS-101, its proprietary gene therapy candidate for the treatment of pediatric spinal muscular atrophy (SMA) Type 1. AVXS-101 had previously been granted orphan drug designation for the treatment of all types of spinal muscular atrophy (SMA) and Fast Track designation for the treatment of SMA Type 1. Breakthrough Therapy Designation is given to a drug intended alone or…

Continue Reading

WednesdayJul 20, 2016 3:11 pm

SolarCity Corp. (SCTY) Adds $345 Million in Tax Equity to Fund Solar Projects

In a recent news release, SolarCity Corp. (NASDAQ: SCTY) announced the addition of $345 million in tax equity to its coffers through deals with four separate partners executed in June and July. These financing facilities will cover the capital cost of new equipment and installations, effectively allowing customers to pay less for solar power than they would for grid power. In addition to these new funds, SolarCity also increased its existing debt aggregation facility by $110 million, bringing the total to $760 million. To date, the company’s capital markets team has successfully raised more than $1.5 billion in project financing…

Continue Reading

WednesdayJul 20, 2016 3:03 pm

SoftBank (SFTBY) to Acquire ARM Holdings (ARMH) for $31.4 Billion

SoftBank Group (“SoftBank”) (OTC: SFTBY) and ARM Holdings plc (“ARM”) (NASDAQ: ARMH) have announced agreement on the terms of a recommended acquisition by SoftBank of the entire issued and to be issued share capital of ARM for cash. The acquisition may be executed by SoftBank, or, at Softbank’s election, a wholly-owned subsidiary of SoftBank. Under the acquisition agreement, each ARM shareholder will be offered 1,700 pence (UK) in cash for each share held. The offer price of 1,700 pence corresponds to an acquisition premium of about 43.0 percent to ARM’s closing price, on Friday, July 15, 2016, of 1,189 pence.…

Continue Reading

WednesdayJul 20, 2016 8:30 am

Ballard Power Systems (BLDP) Enters Definitive Agreement for Production of Fuel Cell Stacks in Guangdong, China

In a recent news release, Ballard Power Systems (NASDAQ: BLDP) announced its entry into definitive agreements with China’s Guangdong Nation Synergy Hydrogen Power Technology Co. Ltd. (“Synergy”) for the establishment of an FCvelocity®-9SSL fuel cell stack production operation in the City of Yunfu, which is located in Guangdong Province. The resulting fuel cell stacks will be packaged directly into locally-assembled fuel cell engines and integrated into zero-emission buses and commercial vehicles operating throughout China. Subject to closing, this transaction is expected to offer a minimum value of $168 million to Ballard over a period of five years. Ballard will receive…

Continue Reading

TuesdayJul 19, 2016 5:19 pm

Content Checked (CNCK) App Highlighted in Energy Times Magazine

The June issue of Energy Times Magazine gave readers a look into the potential health benefits associated with use of the SugarChecked app from Content Checked Holdings, Inc. (OTCQB: CNCK). The publication’s editor gave SugarChecked a stellar review, noting its utility as a tool to manage obesity, type 2 diabetes, and metabolic syndrome. “If you’re looking to lose weight, one way is to avoid sugar,” reads Energy Times’ June ‘Wellness Watch’ spotlight. “It isn’t always easy to find added sweetness in packaged foods, though, given that there are dozens of ways to say “sugar” on food labels. One way to…

Continue Reading

Contact us: 212.418.1217